All articles A–Z
519,064 articles
Fluorometer
A fluorometer, also spelled fluorimeter, is an instrument that measures the intensity and wavelength distribution of fluorescence from excited molecules, in forms from benchtop filter devices to sensors deployed in rivers and groundwater.
Fluorometholone
Fluorometholone (FML, Flarex) is a synthetic topical glucocorticoid, C22H29FO4, first approved 1972, used as 0.1% eye drops for steroid-responsive ocular inflammation, with lower intraocular pressure-raising risk than dexamethasone or prednisolone.
Fluorophenol
Fluorophenols are phenols bearing one or more fluorine atoms directly on the aromatic ring, used chiefly as intermediates in pharmaceutical, agrochemical, and liquid-crystal manufacture; 4-fluorophenol builds drugs like cisapride.
Fluorophore
Fluorophore: a molecular entity, often organic, that emits fluorescence after absorbing light at a shorter excitation wavelength. Families include organic dyes (FITC, Alexa Fluor), fluorescent proteins (GFP), and quantum dots; used in microscopy, flow cytometry, and FRET.
Fluoroquinolone resistant Campylobacter
Fluoroquinolone-resistant Campylobacter: C. jejuni and C. coli strains resistant to ciprofloxacin, arising via gyrA point mutations, spread from poultry to humans, now at 70–85% in EU surveillance.
Fluoroquinolone resistant Escherichia coli
Fluoroquinolone-resistant Escherichia coli: E. coli strains resistant to ciprofloxacin and levofloxacin via gyrA/parC mutations, AcrAB-TolC efflux, and plasmid-mediated qnr genes; about 39% resistant in US hospitals in 2024.
Fluoroquinolone resistant Klebsiella pneumoniae
Fluoroquinolone resistant Klebsiella pneumoniae: strains of the nosocomial pathogen resistant to ciprofloxacin and levofloxacin via gyrA/parC QRDR mutations, efflux, and qnr plasmid-mediated resistance; resistance rose from 12.9% to 35.6% (1991–2005).
Fluoroquinolone resistant Neisseria gonorrhoeae
Fluoroquinolone resistant Neisseria gonorrhoeae (QRNG): gonococcal strains resistant to ciprofloxacin and ofloxacin via gyrA and parC mutations; CDC ended fluoroquinolone gonorrhea treatment in 2007.
Fluoroquinolone resistant Salmonella
Fluoroquinolone resistant Salmonella: Salmonella strains resistant to ciprofloxacin-class antibiotics, driven by gyrA/parC QRDR mutations, efflux pumps, and plasmid-mediated qnr genes; WHO high-priority pathogen since 2017, ICD-11 MG50.90.
Fluoroquinolone resistant Shigella
Fluoroquinolone resistant Shigella: ciprofloxacin-resistant Shigella strains driven by gyrA/parC QRDR mutations and qnr plasmid genes; WHO high-priority pathogen, rising from 0.6% to 29% in Asia and Africa, now part of XDR shigellosis clusters.
Fluoroquinolone resistant Vibrio
Fluoroquinolone resistant Vibrio (ICD-11 MG50.B0) denotes Vibrio strains resistant to fluoroquinolones such as ciprofloxacin, driven by gyrA/parC QRDR mutations, efflux, and PMQR genes; prevalence varies by species, from near zero in O1/O139 V. cholerae environmental isolates to high quinolone resistance in Asian clinical cholera surveillance.
Fluoroscopy
Fluoroscopy, or fluoroscopic imaging, is a medical imaging technique that shows a continuous real-time X-ray image on a monitor, like an X-ray movie, used to diagnose conditions and guide procedures such as catheter placement.
Fluorosulfonylation
Fluorosulfonylation is the introduction of the fluorosulfonyl group (–SO₂F) into an organic molecule, forming sulfonyl fluorides that serve as connective hubs of SuFEx click chemistry.
Fluorotelomer carboxylic acids
Fluorotelomer carboxylic acids (FTCAs) are polyfluoroalkyl carboxylic acids with a perfluorinated tail and hydrogen-bearing head, formed mainly as intermediates in the environmental breakdown of fluorotelomer alcohols.
Fluorouracil
Fluorouracil (5-FU, 5-fluorouracil) is a fluorinated uracil antimetabolite chemotherapy drug discovered in 1957 by Charles Heidelberger, FDA-approved in 1962, and still the cornerstone of colorectal cancer treatment via thymidylate synthase inhibition.
Fluorous phase
The fluorous phase is the fluorocarbon-rich phase of a two-liquid system, mostly perfluorinated alkanes and ethers, underlying fluorous biphasic catalysis, introduced by Horváth and Rábai in 1994.
Fluoxapiprolin
Fluoxapiprolin (CAS 1360819-11-9), a Bayer piperidinyl thiazole isoxazoline OSBPI fungicide (FRAC 49) for oomycete diseases such as late blight and downy mildew; sold as Xivana; not EU-approved, registered in Canada, US, New Zealand.
Fluoxastrobin
Fluoxastrobin (HEC 5725; trade names Evito, Disarm) is a strobilurin QoI fungicide, CAS 361377-29-9, first registered in the US in 2005 by Bayer CropScience, controlling blights, leaf spots, and rusts on vegetables, peanuts, and turf.
Fluoxetine
Fluoxetine (Prozac) is the first marketed SSRI antidepressant, developed by Eli Lilly (Fuller, Wong, Molloy), FDA-approved December 1987 for depression, OCD, bulimia, and panic disorder, patent expired 2001.
Fluoxymesterone
Fluoxymesterone (Halotestin, FXM) is a synthetic 17-alpha-alkylated androgenic anabolic steroid, first FDA-approved in 1956 and now discontinued, used orally for male hypogonadism, delayed puberty, and palliative treatment of inoperable metastatic breast cancer.
Flupenthixol
Flupenthixol is a first-generation thioxanthene antipsychotic drug, first available in the United Kingdom in 1965, used to treat schizophrenia as tablets or a long-acting injection and, at low doses, depression with or without anxiety.
Flupentixol
Flupentixol (flupenthixol), thioxanthene first-generation antipsychotic, ATC N05AF01, brands Depixol, Psytixol, Fluanxol; oral and decanoate depot forms for schizophrenia; D1/D2 blockade; 2-4 week depot action.
Fluphenazine
Fluphenazine is a high-potency typical antipsychotic of the phenothiazine class, used for psychosis in schizophrenia and available as oral tablets or a long-acting decanoate injection.
Flupirtine
Flupirtine, a triaminopyridine non-opioid analgesic and selective neuronal potassium channel opener (Kv7/GIRK activator), was used in Europe from 1984 for pain with muscle tension until EMA withdrew it in 2018 over liver injury.
Flupoxam
Flupoxam (MON 18500, KNW-739) is a triazole carboxamide cellulose-biosynthesis-inhibitor herbicide introduced in 1989 for broadleaf weed control in winter cereals; targeting CESA1/CESA3, it is no longer EU-approved.
Fluprednisolone
Fluprednisolone (6α-fluoroprednisolone, Alphadrol) is a synthetic fluorinated glucocorticoid, C21H27FO5, about 2.5 times as potent as prednisolone; FDA-approved 1982, now discontinued.
Flupyrsulfuron methyl
Flupyrsulfuron-methyl, typically applied as its sodium salt flupyrsulfuron-methyl-sodium, is a DuPont sulfonylurea herbicide for grass and broadleaf weeds in cereals, inhibiting acetolactate synthase at rates near 12 grams per hectare.
Fluquinconazole
Fluquinconazole, a triazole (conazole) fungicide introduced by Schering in 1992, used mainly as a cereal take-all and canola blackleg seed treatment; EU-approved 2012-2021, later withdrawn in Great Britain.
Flurandrenolide
Flurandrenolide (fludroxycortide, brand Cordran) is a synthetic fluorinated topical corticosteroid for corticosteroid-responsive dermatoses, available as 0.05% cream, ointment, lotion, and 4 mcg/cm2 tape; FDA-approved 1965.
Flurazepam
Flurazepam is a long-acting benzodiazepine used mainly as a hypnotic for insomnia. Introduced in the United States in 1970 under the brand name Dalmane, it rapidly supplanted barbiturates for treating insomnia.